KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BMRN
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

BioMarin Pharmaceutical Inc. stock price fell more than -9.90% Thursday closing at $82.17
(Updated on Apr 25, 2024)

Sell candidate since Apr 25, 2024 PDF

The BioMarin Pharmaceutical Inc. stock price fell by -9.90% on the last day (Thursday, 25th Apr 2024) from $91.20 to $82.17. During the last trading day the stock fluctuated 7.14% from a day low at $81.00 to a day high of $86.78. The price has fallen in 7 of the last 10 days and is down by -10.16% for this period. Volume has increased on the last day by 6 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 8 million shares were bought and sold for approximately $647.70 million.

The stock has broken the wide and horizontal trend down. Breaks like this are often followed by swift and strong movements, and any correction down to the breakline at approximately $83.75 is considered to be a "second chance" to get out before further fall. It is, however, important to note that false breaks may appear and that the price may move back into the horizontal trend. A break on increasing volume is considered to be more significant and reliable than breaks on low volume.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BMRN Signals & Forecast

There are few to no technical positive signals at the moment. The BioMarin Pharmaceutical Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $89.16 and $87.44. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, April 12, 2024, and so far it has fallen -10.90%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for BioMarin Pharmaceutical Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $5.78 (7.14%) between high and low. For the last week, the stock has had daily average volatility of 3.00%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BMRN) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect BioMarin Pharmaceutical Inc. to open at $83.32, and during the day (based on 14 day Average True Range), to move between $79.78 and $84.56, which gives a possible trading interval of +/-$2.39 (+/-2.91%) up or down from last closing price. If BioMarin Pharmaceutical Inc. takes out the full calculated possible swing range there will be an estimated 5.81% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $86.28, some $4.11 (5.00%) from the current price of $82.17, our system finds the risk reward not very attractive.

Is BioMarin Pharmaceutical Inc. stock A Buy?

BioMarin Pharmaceutical Inc. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Sell candidate.

Current score: -5.419 Strong Sell Candidate Downgraded

Predicted Opening Price for BioMarin Pharmaceutical Inc. of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
$83.32 ( 1.40%) $82.17

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BMRN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 89.10 8.43 %
R2 86.89 5.74 %
R1 85.52 4.08 %
Current price: 82.17
Support S1 81.11 -1.29 %
S2 79.74 -2.95 %
S3 77.54 -5.64 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 92.22 12.23 %
R2 91.24 11.04 %
R1 86.28 5.00 %
Current price 82.17
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for BioMarin Pharmaceutical Inc. Stock and on which exchange is it traded?
The symbol for BioMarin Pharmaceutical Inc. is BMRN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell BioMarin Pharmaceutical Inc. Stock?
BioMarin Pharmaceutical Inc. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Sell candidate.

How to buy BioMarin Pharmaceutical Inc. Stock?
BioMarin Pharmaceutical Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy BioMarin Pharmaceutical Inc. Stock.

What's the current price of BioMarin Pharmaceutical Inc. Stock?
As of the end of day on the Apr 25, 2024, the price of an BioMarin Pharmaceutical Inc. (BMRN) share was $82.17.

What is the 52-week high and low for BioMarin Pharmaceutical Inc. Stock?
The 52-week high for BioMarin Pharmaceutical Inc. Stock is $99.55 and the 52-week low is $76.02.

What is the market capitalization of BioMarin Pharmaceutical Inc. Stock?
As of the Apr 25, 2024, the market capitalization of BioMarin Pharmaceutical Inc. is 15.594B.

When is the next earnings date for BioMarin Pharmaceutical Inc.?
The upcoming earnings date for BioMarin Pharmaceutical Inc. is Jul 29, 2024.
Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT